Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.06.23.661164

EEG-GAN: A Generative EEG Augmentation Toolkit for Enhancing Neural Classification

Abstract

Electroencephalography (EEG) is a widely applied method for decoding neural activity, offering insights into cognitive function and driving advancements in neurotechnology. However, decoding EEG data remains challenging, as classification algorithms typically require large datasets that are expensive and time-consuming to collect. Recent advances in generative artificial intelligence have enabled the creation of realistic synthetic EEG data, yet no method has consistently demonstrated that such synthetic data can lead to improvements in EEG decodability across diverse datasets. Here, we introduce EEG-GAN, an open-source generative adversarial network (GAN) designed to augment EEG data. In the most comprehensive evaluation study to date, we assessed its capacity to generate realistic EEG samples and enhance classification performance across four datasets, five classifiers, and seven sample sizes, while benchmarking it against six established augmentation techniques. We found that EEG-GAN, when trained to generate raw single-trial EEG signals, produced signals that reproduce grand-averaged waveforms and time-frequency patterns of the original data. Furthermore, training classifiers on additional synthetic data improved their ability to decode held-out empirical data. EEG-GAN achieved up to a 16% improvement in decoding accuracy, with enhancements consistent across datasets but varying among classifiers. Data augmentations were particularly effective for smaller sample sizes (30 and below), significantly improving 70% of these classification analyses and only significantly impairing 4% of analyses. Moreover, EEG-GAN significantly outperformed all benchmark techniques in 69% of the comparisons across datasets, classifiers, and sample sizes and was only significantly outperformed in 3% of comparisons. These findings establish EEG-GAN as a robust toolkit for generating realistic EEG data, which can effectively reduce the costs associated with real-world EEG data collection for neural decoding tasks.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Williams, C. C., Weinhardt, D., Hewson, J., Plomecka, M. B., Langer, N., Musslick, S.. 2025-06-25. EEG-GAN: A Generative EEG Augmentation Toolkit for Enhancing Neural Classification. https://doi.org/10.1101/2025.06.23.661164

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗